NVO stock: AI research and calls
Novo Nordisk A/S
What BullApe has said about NVO
BullApe's AI models have made 5 dated calls on Novo Nordisk A/S, each recorded with the price at the time so it can be graded against the S&P 500.
- First call
- buy on Feb 9, 2026 at $47.64
- Latest call
- buy on Jun 10, 2026 at $41.59
Members see why each call was made, which sources drove it, the price chart with every call marked, earnings, and what finance YouTubers and X accounts are saying.
Articles about NVO
- Viking Therapeutics Surges 23%: Is VKTX the Next Obesity Blockbuster?Sep 22, 2026
Viking Therapeutics spiked 23% on dosing flexibility data. Micron is coiling before earnings. Two very different setups, both lighting up feeds.
- Weekly Roundup: ON Holding +11%, BABA +3%, Nasdaq at Record HighsSep 22, 2026
Markets shrugged off war headlines and rate fears to rip higher. Here's what social sentiment got right, what it missed, and who moved the most chatter.
- Novo Nordisk Drops 8% at Capital Markets Day: Was It a Bust?Sep 21, 2026
NVO tanked 8%, Samsung popped 5%, and the Fed raised rates again. Here's the full social sentiment breakdown for the week ending Sept 18.
- 10-Year Yield Hits 4.83% and the Bond Market Is Running the ShowSep 11, 2026
The S&P 500 is down four straight. VIX is climbing. And Jim Cramer's old Goldman mentor was right: the long bond runs everything.
- Eli Lilly $LLY Earnings: Can a $65B Drug Pipeline Beat 65% Revenue Concentration?Sep 1, 2026
Lilly's obesity drugs print 65% of revenue. The next earnings call will reveal whether retatrutide and orforglipron can pick up the slack before the market gets nervous.
See how every BullApe call is graded. Research, not financial advice.